BioLife (BLFS) Year-over-year net earnings per share growth for the last 12 months
Strict FDA standards and the integration of freezing tools into clinical protocols create a high barrier to entry for competitors of BioLife Solutions, Inc. (BLFS). The quarterly percentage change in EPS reflects revenue dynamics, where the latest parameter stands at 376.30. Environmental policy is based on plastic recycling and energy efficiency. The moderate cyclicality of demand for cryopreservation is offset by the long-term development of biotechnology.
Financial and market metric breakdowns for BioLife (BLFS)
- share price and expert price forecast:
- market capitalization details:
- book capitalization indicators:
- business debt structure and liquidity details:
Debt to Equity BioLife Solutions, Inc.|BLFS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BioLife Solutions, Inc.|BLFS - Company Aggregate Debts|Debt to Book Value BioLife Corp|BLFS - Amount of Long-Term Liabilities|Company Short-Term Debts BioLife Solutions|Quick Liquidity biolifesolutions.com
- earnings and market multiples details:
BLFS - Company Net Income|Expected Profit BioLife Solutions, Inc.|BLFS - Price to Earnings Multiple|Future Price to Earnings BioLife Corp|BLFS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio BioLife Corp|BLFS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) BioLife Solutions|BLFS - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months biolifesolutions.com|BLFS - Earnings per share growth this year|Earnings growth forecast for next year BioLife Solutions, Inc.
Initial company analysis:BioLife Solutions, BLFS
BioLife Solutions, Inc. (BLFS) provides the infrastructure for cryopreservation within the gene therapy sector. The analyzed quarterly EPS growth rate reflects the dynamics of net income per share, excluding market noise. The growth of this indicator confirms the effectiveness of business scaling while maintaining strict adherence to medical standards. This positive trajectory demonstrates the resilience of cash flows to biopharmaceutical shocks. This asset is categorized as a high-tech security.
Competitor analysis for BioLife Solutions, Inc.
TEM: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Qiagen NV (QGEN)|Year-over-year net earnings per share growth for the last 12 months IONS|RGEN: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Avidity Biosciences (RNA)|Year-over-year net earnings per share change for the last twelve months crisprtx.com|Year-over-year earnings per share growth for the last twelve months GeneDx WGS|Ultragenyx Pharmaceutical Inc. (RARE) - Earnings per share growth in annualized terms for the last twelve months|BEAM - Year-over-year earnings per share growth for the last twelve months|SRPT: Year-over-year earnings per share growth for the last twelve months|TWST (Twist Bioscience) - Year-over-year net earnings per share growth for the last 12 months|10xgenomics.com (TXG) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months NTLA|STOK (Stoke Therapeutics Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth WVE|Year-over-year net earnings per share change for the last twelve months Maze Therapeutics Corp|Year-over-year earnings per share growth for the last twelve months Sionna Therapeutics Inc SION|primemedicine.com (PRME) - Earnings per share growth in annualized terms for the last twelve months|TSHA - Year-over-year earnings per share growth for the last twelve months|QURE (uniQure NV) - Year-over-year earnings per share growth for the last 12 months|MeiraGTx PLC (MGTX) - Year-over-year earnings per share growth for the last twelve months|RGNX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months SLDB|OCGN: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PACB|Year-over-year net earnings per share change for the last twelve months Benitec Biopharma Inc|Year-over-year earnings per share growth for the last twelve months Design Pharma DSGN|RCKT: Year-over-year earnings per share growth for the last 12 months|4D Molecular Therapeutics - Quarterly EPS earnings growth|Lexeo Therapeutics (LXEO) - Year-over-year net earnings per share growth for the last 12 months|KRRO (korrobio.com) - Year-over-year net earnings per share growth for the last 12 months|EDIT - Year-over-year net earnings per share change for the last twelve months|SLN (Silence Therapeutics Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months PRQR|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|Year-over-year earnings per share growth for the last twelve months SGMO (sangamo.com)|Quarterly EPS earnings growth NAUT (Nautilus Bio)|MGX (Metagenomi Inc.) - Year-over-year net earnings per share trend for the last twelve months|DTIL - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Generation Bio Co. GBIO|BOLD: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months XCUR|Year-over-year earnings per share growth for the last twelve months Imunon Inc|Year-over-year earnings per share growth for the last 12 months PHIO (RXi Pharmaceuticals)|Quarterly EPS earnings growth MBIO|Quarterly EPS earnings growth transcodetherapeutics.com (RNAZ)|Quarterly EPS earnings growth BNGO (Bionano Genomics)|adnas.com - Year-over-year earnings per share growth for the last twelve months|bluebird bio - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months ImmunoPrecise Antibodies IPA|Omega (OMGA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Singular Genomics Corp (OMIC)|Year-over-year earnings per share growth for the last twelve months Regulus Therapeutics|Year-over-year earnings per share growth for the last twelve months SYRS|Quarterly EPS earnings growth TBIO|Year-over-year net earnings per share change for the last twelve months TRACON Pharmaceuticals Inc.|Quarterly EPS earnings growth UBX (Unity Bio)
